1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Jeffrey Curtis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19 VaccinE Response in Rheumatology Patients Upadacitinib, Abatacept, Secukinumab - Rheumatoid Arthritis, Psoriatic Arthritis | Phase 4 | Completed | Jeffrey Curtis | 841 | 2021-11-15 | 2025-05-02 |
Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Spondylarthritis (1)
Abatacept (1) · Adalimumab (1) · Certolizumab Pegol (1) · Etanercept (1) · Tumor Necrosis Factor Inhibitors (1) · baricitinib (1) · canakinumab (1) · ixekizumab (1) · secukinumab (1) · tofacitinib (1) · upadacitinib (1)
United States (1)
Jeffrey R Curtis, MD MS MPH (1)